Related Experiment Videos
Deoxycorticosterone, 11 beta-hydroxylase and the adrenal cortex
H A Spoudeas1, J D Slater, G Rumsby
1Endocrine Unit, Middlesex Hospital, London, UK.
Clinical Endocrinology
|August 1, 1993
Summary
Congenital adrenal hyperplasia (CAH) caused severe hypertension in a child due to excess deoxycorticosterone (DOC). Treatment required both glucocorticoid and mineralocorticoid replacement, confirming DOC
Area of Science:
- Endocrinology
- Pediatric Nephrology
- Genetics
Background:
- Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting the adrenal glands.
- 11 beta-hydroxylase deficiency is a specific form of CAH leading to hormonal imbalances.
- Deoxycorticosterone (DOC) excess can cause severe hypertension.
Observation:
- A pediatric case of malignant hypertension secondary to DOC excess from CAH (11 beta-hydroxylase deficiency) is presented.
- The patient exhibited severe clinical and metabolic disturbances attributable to hormonal dysregulation.
Findings:
- Successful clinical and metabolic control was achieved solely through combined glucocorticoid and mineralocorticoid replacement therapy.
- This therapeutic outcome supports the hypothesis of dual DOC production sites within the adrenal cortex.
Implications:
- Confirms the clinical hypothesis that deoxycorticosterone originates from both zona fasciculata and zona glomerulosa.
- Highlights the independent regulatory roles of ACTH and the renin-angiotensin system in DOC synthesis.
- Underscores the importance of comprehensive hormonal replacement in managing complex CAH cases.